The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market reached US$ 3.57 Bn in 2022 (up by 4.7% over 2021). Outbreak of Covid-19 in the short-term, backed by “innovation” in the long run, is expected to drive the market.
Sepsis, toxic shock syndrome, bacteremia, osteomyelitis, endocarditis, meningitis, pneumonia are amongst the life-threatening diseases caused by Staphylococcus Aureus bacteria. These diseases are cured by antibiotics.
Some form of staphylococcus aureus that has developed resistance to a broad range of antibiotics fall in the category of “Methicillin-Resistant Staphylococcus Aureus (MRSA)”. This resistance is one of the key factors driving the market in the near future as well as extensive research ought to be on the anvil to devise new medications.
Request a report sample to gain comprehensive insights at
According to FMI’s latest study, the rising incidences of MRSA all over the world are likely to create demand for safe and efficient drugs during the forecast period.
|Data Points||Market Insights|
|Market Value 2022||USD 3.9 Bn|
|Market Value 2030||USD 5.5 Bn|
|Key Players||The key players are Pfizer, Inc., Allergan Plc., Johnsons & Johnson, Colgate-Palmolive Company, The Procter & Gamble, Merck & Co., Inc., Baxter Healthcare Corporation, Fresenius Kabi LLC, Sandoz Inc., Teva Pharmaceutical Industries ltd., Mylan N. V., Dr.Reddy’s Laboratories Inc., Cumberland Pharmaceuticals Inc., Durata Therapeutics Inc., Melinta Therapeutics, Inc., Debiopharm International S.A., Cardinal Health, Amazon Inc., Herbal Intervention, LLC, 3M ESPE Dental Products, Patterson Dental Supply Inc., The Kroger Company, Crown Laboratories, Inc., Atlantic Biologicals Corp., Bio-Germ Protection LLC and Apollo Health and Beauty Care|
|Share of Top 5 Countries||65.9%|
Covid-19 Pandemic: A Short-term Upholsterer
Outbreak of novel corona virus has resulted in short-term considerable increase in the number of MRSA infections. This number is expected to boost the market demand for MRSA antibiotics during the ongoing Covid-19 crisis. As per the latest data, around 2.5 million people have been infected by Covid-19 so far.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-10406
Key Takeaways of MRSA Treatment Market Study
- In terms of drug class, glycopeptides (vancomycin) and oxazolidinones (linezolid) are collectively expected to account for over 75% of revenue share in the MRSA treatment market owing to preference of both antibiotic classes as a first-line treatment against MRSA infections and used in more than 80% of MRSA cases treatment.
- By route of administration, intravenous (IV) route of administration remains the recommended option. Drugs that can be administered through IV are likely to gain more than one-half of market share in the MRSA treatment market during the forecast period.
- By indication, skin and soft tissue infections (SSTIs) are leading the market and expected to gain more than 40% of revenue share followed by the pneumonia over the forecast period.
- Incidence of healthcare acquired MRSA is higher than community acquired MRSA, and FMI opines status-quo to remain unchanged during the assessment period
- North America is the highest revenue generating market by region due to high incidence of MRSA infections
- Asia Pacific is expected to witness high demand for MRSA testing systems due to high incidences of MRSA infection herein. For example – Journal of Family Medicine and Primary Care, in 2021, stated that occurrence of MRSA among kids aged 5 to 15 is between 16 and 52%. India alone accounts for 4-19% of these infections.
Government and Pharma Industry Focus on Working in Unison to Develop Advanced Treate
As per University of Melbourne’s researchers, “Teixobactin” responds positively against MRSA. These results are likely to pave the way for development of antibacterial drugs to treat multi-drug resistant Gram-positive infections with thick cell wall. This will open wider doors for MRSA treatment market all over Australia and the other countries in Asia-Pacific. Teixobactin is already known for destroying Mycobacterium tuberculosis.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-10406
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Hirschsprung Disease Treatment Market – Hirschsprung disease is a condition in which certain nerve fibers are absent in the segment of the bowel results in partial or full blockage of a stool which further leads to severe infection and damage to the colon.
Blepharitis Treatment Market – Blepharitis is an ophthalmologic condition which is characterized by the inflammation of the eyelids which leads to eye irritation. The eyelids of the patient become inflamed near to the eye margin, and usually affects both eyes at the same time.
Dyslexia Treatments Market – Dyslexia is neurologically based and often hereditary. It is associated with difficulties in reading, writing, spelling and organization. Functional Magnetic Resonance Imaging shows that the brains of people with dyslexia develop and function in a different way.
Norovirus Infection Treatment Market – Norovirus is the common viral infection which can affect anyone. It is a contagious infection can be spread through food or water and also by touching the contaminated surface. Norovirus infection leads to stomach pain, nausea, diarrhea and throwing up.
Inherited Retinal Diseases Treatment Market – Inherited retinal diseases (IRDs) are genetically heterogeneous disorders which is one of the cause of blindness. There are more than 100 types of inherited retinal diseases and severity varies significantly.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: firstname.lastname@example.org
For Media Enquiries: email@example.com